Series D · Medtech & Devices · Grenoble, France · Founded 2011 · 51–200 employees
UroMems is a global medical device startup developing active implantable technologies to treat Stress Urinary Incontinence. Its flagship innovation, UroActive, is the first smart, automated electronic artificial urinary sphincter designed to dynamically adjust to real-time patient activity without manual intervention. In May 2026, the company secured a $60 million Series D equity funding round backed entirely by Ajax Health to advance its SOPHIA2 pivotal clinical trials in both Europe and the United States. Founded in 2011, the company has raised significant capital over multiple rounds, positioning itself as a leader in smart urological implants.
No open roles listed right now.